Home › Psychomotor Agitation › Florida
Psychomotor Agitation clinical trials in Florida
6 studies for Psychomotor Agitation are looking for participants at sites in Florida.
Cities in Florida
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2602, Bonita Springs
- Nuovida Research Center, Miami
- Local Institution - 1635, Orlando
- and 3 more
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
- Arrow Clinical Trials, Daytona Beach
- Personal Physician Care, Delray Beach
- Global Medical Institutes Florida LLC, Miami
- and 2 more
RecruitingPhase 2
All ages · All sexes · Updated Sep 16, 2026 · NCT06052254A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2648, Aventura
- Envision Trials LLC, Bonita Springs
- Key Clinical Research, Bradenton
- and 6 more
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Arrow Clinical Trials, Daytona Beach
- ClinCloud, Maitland
- Local Institution - 0007, Maitland
- and 3 more
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
- University of Miami Department of Neurology, Miami
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated May 28, 2026 · NCT06781333Clinical Trial on Agitation in Alzheimer's Dementia
- ClinCloud, LLC, Melbourne
- Central Miami Medical Institute, Miami
- Visionary Investigators Network, Miami
- and 4 more
RecruitingPhase 2
Ages 60 and older · All sexes · Updated May 20, 2026 · NCT05543681From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.